We are live on ! Find out more
Qube Research & Technologies (QRT)

Qube Research & Technologies (QRT) Portfolio holdings

AUM $89.9B
1-Year Est. Return 20.22%
This Fund
S&P 500
This Quarter Est. Return
+5.83%
1 Year Est. Return
+20.22%
3 Year Est. Return
+42.42%
5 Year Est. Return
+23.97%
10 Year Est. Return
AUM
$6.31B
AUM Growth
-$728M
Cap. Flow
-$775M
Cap. Flow %
-12.3%
Top 10 Hldgs %
15.28%
Holding
2,651
New
895
Increased
415
Reduced
539
Closed
791

Sector Composition

Rank Sector Weight
1 Technology 12.84%
2 Financials 10.33%
3 Consumer Discretionary 9.1%
4 Healthcare 7.93%
5 Industrials 7.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NTCO
2526
DELISTED
Natura &Co Holding S.A. American Depositary Shares (each representing two Common Shares)
NTCO
-27,092
Closed -$542K
NVTA
2527
DELISTED
Invitae Corporation
NVTA
-23,510
Closed -$983K
IBDO
2528
DELISTED
iShares iBonds Dec 2023 Term Corporate ETF
IBDO
-8
Closed
PACW
2529
DELISTED
PacWest Bancorp
PACW
-56,944
Closed -$1.45M
HT
2530
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
-29,930
Closed -$236K
NEWR
2531
DELISTED
New Relic, Inc.
NEWR
-22,918
Closed -$1.5M
AKU
2532
DELISTED
Akumin Inc
AKU
-113,923
Closed -$343K
SCPL
2533
DELISTED
SciPlay Corporation Class A Common Stock
SCPL
-12,168
Closed -$169K
RAD
2534
DELISTED
Rite Aid Corporation
RAD
-38,241
Closed -$605K
ZYNE
2535
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
-26,327
Closed -$87K
SDC
2536
DELISTED
SmileDirectClub, Inc. Class A Common Stock
SDC
-25,500
Closed -$304K
INFI
2537
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
-29,087
Closed -$62K
FOCS
2538
DELISTED
Focus Financial Partners Inc. Class A
FOCS
-9,769
Closed -$425K
IDEX
2539
DELISTED
Ideanomics, Inc. Common Stock
IDEX
-445
Closed -$111K
UNVR
2540
DELISTED
Univar Solutions Inc.
UNVR
-84,632
Closed -$1.61M
SPPI
2541
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
-15,400
Closed -$53K
NOVN
2542
DELISTED
Novan, Inc. Common Stock
NOVN
-17,702
Closed -$144K
APTO
2543
DELISTED
Aptose Biosciences, Inc.
APTO
-27
Closed -$53K
DBD
2544
DELISTED
Diebold Nixdorf Incorporated
DBD
-23,991
Closed -$256K
ACOR
2545
DELISTED
Acorda Therapeutics
ACOR
-328
Closed -$27K
BLCM
2546
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
-15,760
Closed -$56K
SGTX
2547
DELISTED
Sigilon Therapeutics, Inc. Common Stock
SGTX
-1,082
Closed -$676K
SUMO
2548
DELISTED
Sumo Logic, Inc. Common Stock
SUMO
-7,837
Closed -$224K
SJR
2549
DELISTED
Shaw Communications Inc.
SJR
-111,876
Closed -$1.97M
DCT
2550
DELISTED
Duck Creek Technologies, Inc. Common Stock
DCT
-10,610
Closed -$459K

Similar funds

Qube Research & Technologies (QRT)'s Q1 2021 Portfolio in Review

As of Q1 2021, Qube Research & Technologies (QRT) held 2,651 positions worth $6.31B, down 10% from $7.03B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Qube Research & Technologies (QRT) withdrew a net $775M in Q1 2021, closing 791 positions and reducing 539 holdings. Its most notable exit was Schwab US Aggregate Bond ETF, an estimated $49.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Qube Research & Technologies (QRT) opened a new position in iShares 3-7 Year Treasury Bond ETF worth $65M.

  • Qube Research & Technologies (QRT)'s largest Q1 2021 buy was iShares 3-7 Year Treasury Bond ETF: 500,551 shares worth $65M.
  • Qube Research & Technologies (QRT) added most to iShares MBS ETF in Q1 2021, an estimated $97.9M increase.
  • Qube Research & Technologies (QRT)'s biggest Q1 2021 reduction was iShares National Muni Bond ETF, cutting an estimated $112M.
  • Qube Research & Technologies (QRT) fully exited Schwab US Aggregate Bond ETF in Q1 2021, selling an estimated $49.9M.
  • Qube Research & Technologies (QRT)'s ten largest holdings make up 15% of its $6.31B portfolio in Q1 2021.
  • Qube Research & Technologies (QRT) opened 895 new positions and closed 791 in Q1 2021.
  • Qube Research & Technologies (QRT)'s portfolio value fell 10% quarter-over-quarter to $6.31B.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2021, filed 14 May 2021.